Patients who discontinued GLP-1s had more weight gain, complications during pregnancy In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs
How to get approved for Wegovy If your TRICARE healthcare plan does not initially cover Wegovy, you still have a few options for getting approved
In the liraglutide group, participants, on average, lost 8.4 kilograms of body weight, with a range of 7.3 kilograms above or below that average
Nutritional support during GLP-1 treatment cannot be overstated
Semaglutide mimics the natural GLP-1 hormone to slow gastric emptying and suppress appetite at the hypothalamic level
Drugmaker Eli Lilly, which makes Zepbound, is also testing its obesity medications in children ages six and up